Yasuji Arase Selected Research

Interferon-beta

1/2011	Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients.
1/2010	Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients with genotype 1b and high virus load.
1/2010	Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients with genotype 2 and high virus load.
1/2009	The efficacy of interferon-beta monotherapy for elderly patients with type C hepatitis of genotype 2.
1/2008	Natural human interferon beta plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus and a high viral load.
1/2008	The efficacy of short-term interferon-beta therapy for chronic hepatitis C patients with low virus load.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuji Arase Research Topics

Disease

84	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 01/2002
51	Chronic Hepatitis C 12/2020 - 01/2002
50	Chronic Hepatitis B 10/2023 - 01/2002
50	Infections 10/2019 - 01/2002
37	Fibrosis (Cirrhosis) 04/2021 - 01/2002
29	Liver Cirrhosis (Hepatic Cirrhosis) 02/2020 - 01/2002
26	Hepatitis 08/2012 - 01/2002
24	Neoplasms (Cancer) 01/2023 - 01/2003
21	Liver Diseases (Liver Disease) 10/2022 - 01/2002
18	Hepatitis B 01/2022 - 01/2002
16	Chronic Hepatitis (Chronic Active Hepatitis) 03/2014 - 01/2003
15	Non-alcoholic Fatty Liver Disease 07/2023 - 01/2009
14	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2009
11	Carcinogenesis 01/2014 - 01/2003
9	Liver Neoplasms (Liver Cancer) 07/2023 - 12/2010
9	Diabetes Mellitus 07/2023 - 11/2008
9	Hepatitis C 11/2015 - 09/2005
8	Hypertension (High Blood Pressure) 01/2023 - 09/2009
7	Fatty Liver 04/2022 - 09/2009
6	Anemia 10/2014 - 07/2004
5	Insulin Resistance 01/2022 - 06/2009
5	Viremia 01/2017 - 01/2007
4	Virus Diseases (Viral Diseases) 04/2021 - 01/2004
4	Body Weight (Weight, Body) 01/2018 - 10/2007
4	Disease Progression 01/2014 - 01/2004
3	Hyperuricemia 02/2020 - 05/2010
3	Lymphoma (Lymphomas) 12/2019 - 04/2003
3	Hepatic Encephalopathy 12/2019 - 10/2004
3	Chronic Renal Insufficiency 03/2019 - 10/2011
3	Prediabetic State (Prediabetes) 12/2013 - 01/2009
3	Liver Failure 09/2012 - 01/2004
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2012 - 05/2010
2	Albuminuria 01/2023 - 01/2020
2	Hyperglycemia 01/2023 - 06/2010
2	Fever (Fevers) 10/2022 - 03/2012
2	Autoimmune Hepatitis 10/2022 - 07/2010

Drug/Important Bio-Agent (IBA)

69	InterferonsIBA 12/2020 - 01/2002
33	Ribavirin (Virazole)FDA LinkGeneric 01/2018 - 01/2002
33	Lamivudine (Epivir)FDA Link 05/2017 - 01/2002
27	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2004
26	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2003
23	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 02/2002
22	Hepatitis B e AntigensIBA 03/2014 - 01/2002
16	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2023 - 01/2002
15	Alanine Transaminase (SGPT)IBA 03/2016 - 01/2003
11	entecavir FDA Link 01/2022 - 06/2007
10	lenvatinibIBA 10/2023 - 01/2020
10	AntigensIBA 01/2022 - 01/2002
9	Amino Acids FDA Link 09/2015 - 08/2008
9	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 03/2015 - 01/2006
8	Glucose (Dextrose)FDA LinkGeneric 02/2020 - 07/2011
7	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2020 - 01/2003
7	BilirubinIBA 10/2017 - 01/2003
7	miriplatinIBA 06/2017 - 01/2011
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 08/2008
6	Serum AlbuminIBA 10/2017 - 10/2007
6	adefovir dipivoxil (Hepsera)FDA Link 06/2014 - 01/2004
6	Transaminases (Aminotransferases)IBA 03/2012 - 08/2004
6	Interferon-betaIBA 01/2011 - 01/2008
5	NucleotidesIBA 02/2022 - 09/2004
5	Fetal Proteins (Fetoprotein)IBA 04/2021 - 09/2013
5	lipoarabinomannan (LAM)IBA 05/2017 - 06/2008
5	telaprevirIBA 10/2014 - 01/2010
5	adefovirIBA 06/2014 - 01/2004
5	AlbuminsIBA 07/2013 - 01/2009
5	Interferon-alpha (Interferon Alfa)IBA 12/2010 - 02/2002
4	Cell-Free Nucleic AcidsIBA 01/2023 - 12/2020
4	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2017
4	Protease Inhibitors (Protease Inhibitor)IBA 01/2017 - 01/2010
4	CreatinineIBA 03/2016 - 03/2013
4	Aspartic Acid (Aspartate)FDA Link 04/2010 - 05/2004
4	Proteins (Proteins, Gene)FDA Link 01/2010 - 03/2006
3	Hemoglobins (Hemoglobin)IBA 07/2023 - 11/2004
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 02/2002
3	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2017
3	CanagliflozinIBA 01/2022 - 05/2019
3	TransferasesIBA 04/2021 - 08/2004
3	Tenofovir (Viread)FDA Link 04/2021 - 01/2014
3	Ethanol (Ethyl Alcohol)IBA 01/2021 - 03/2013
3	SofosbuvirIBA 01/2018 - 01/2017
3	NucleosidesIBA 05/2017 - 06/2007
3	asunaprevirIBA 01/2017 - 03/2016
3	daclatasvirIBA 01/2017 - 03/2016
3	Dihydrotachysterol (AT 10)IBA 01/2014 - 03/2009
3	PlatinumIBA 03/2013 - 04/2009
3	LDL CholesterolIBA 08/2012 - 05/2010
3	Tyrosine (L-Tyrosine)FDA Link 04/2010 - 05/2004
3	Methionine (L-Methionine)FDA Link 04/2010 - 05/2004
2	GlycolipidsIBA 09/2023 - 11/2020
2	ORALIT (ORS)IBA 01/2023 - 12/2013
2	Tumor Biomarkers (Tumor Markers)IBA 04/2022 - 01/2008
2	tenofovir alafenamideIBA 02/2022 - 11/2021

Therapy/Procedure

135	Therapeutics 10/2023 - 01/2002
15	Radiofrequency Ablation 02/2019 - 01/2002
5	Retreatment 03/2019 - 04/2003
5	Drug Tapering 10/2012 - 07/2004
4	Drug Therapy (Chemotherapy) 09/2013 - 11/2011
3	Aftercare (After-Treatment) 02/2021 - 12/2006
2	Precision Medicine 01/2023 - 04/2022
2	Plasma Exchange 10/2022 - 10/2004